More than 6 in 10 Americans will have a cardiovascular disease by 2050, according to a new report from the American Heart Association (AHA).
O reportpublished Tuesday in the journal Circulation, found that cardiovascular diseases, including hypertension, “will affect more than 184 million adults by 2050,” or about 61% of Americans.
The prevalence of coronary heart disease among U.S. adults is estimated to increase from 7.8 percent in 2020 to 9.2 percent in 2050, while heart failure will increase from 2.7 percent to 3.8 percent in the same period.
Thanks for signing up!
Sign up for more newsletters here
Subscribe
if (window.checkSizeClasses && window.checkSizeClasses function instance) window.checkSizeClasses();
“As the American Heart Association enters its second century, our future is about improving yours,” Nancy Brown, CEO of the AHA, he said in a press release. “It is crucial to quantify the total burden of cardiovascular disease so that we can better inform community- and health system-level policies and interventions needed to change this current path.”
The report states that “clinical and public health interventions are needed to effectively manage, contain and even reverse” the “prevalence of many cardiovascular risk factors and most established diseases” which are expected to increase in the coming decades.
“We recognize that the cardiovascular health landscape will change over the next three decades due to the approaching tsunami, with rising healthcare costs, an older population living longer, and a growing number of people from resource-poor populations ,” Brown said in a statement.
“The conclusions of these important warnings predict a dire human and economic impact from heart disease and stroke if changes are not made. However, this does not need to be the reality of our future.”
A recent study found that fish oil can potentially increase the risk of stroke and heart problems for those who do not have heart problems, although the supplements are a source of omega-3 fatty acids and are considered useful in treating cardiovascular disease. .
This story originally appeared on thehill.com read the full story